Createrna
Wuhan, CN · 3 known investors
Landos Technology (朗来科技) is a clinical-stage drug discovery and development company with a pipeline of novel small-molecule therapies for indications including hypertension, chronic heart failure, IgA nephropathy, FSGS, chronic cough, idiopathic pulmonary fibrosis, and autoimmune diseases such as rheumatoid arthritis and psoriasis. It operates an end-to-end R&D system spanning proof of concept, candidate screening, preclinical development, and clinical research.
Investors · 3
In the news
Frequently asked questions
- What does Createrna do?
- Landos Technology (朗来科技) is a clinical-stage drug discovery and development company with a pipeline of novel small-molecule therapies for indications including hypertension, chronic heart failure, IgA nephropathy, FSGS, chronic cough, idiopathic pulmonary fibrosis, and autoimmune diseases such as rheumatoid arthritis and psoriasis. It operates an end-to-end R&D system spanning proof of concept, candidate screening, preclinical development, and clinical research.
- Who are Createrna's investors?
- Createrna's investors include OrbiMed, Vivo Capital, Lilly Asia Ventures.
- Where is Createrna headquartered?
- Createrna is headquartered in Wuhan, CN.